期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 24, 期 2, 页码 257-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2010.01.010
关键词
Hematopoietic stem cell transplantation; Opportunistic infections; GVHD
Hematopoietic stem cell transplantation (HSCT) is a treatment for multiple medical conditions that result in bone marrow failure and as an antineoplastic adoptive immunotherapy for hematologic malignancies. HSCT is associated with profound compromises in host barriers and all arms of innate and acquired immunity. The degree of immune compromise varies by type of transplant and overtime, Immune reconstitution occurs within several months after autologous HSCT but takes up to a year or longer after allogeneic HSCT. In those patients who develop chronic graft-versus-host disease, immune reconstitution may take years or may never completely develop. Over time, with strengthening immune reconstitution and control of graft-versus-host disease, the risk for infection dissipates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据